Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger

24 Feb 2015

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Ovarian function and disorders
Share to Reproductive Biology and Fertility

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 25724740
DOI: 10.1016/j.fertnstert.2015.02.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist triggerPMID 25724740Read ↗

Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cyclesSemantic proximity Read ↗

Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndromeSemantic proximity Read ↗

Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndromeSemantic proximity Read ↗

Ovarian hyperstimulation syndrome: A review of pathophysiologySemantic proximity Read ↗

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coastingSemantic proximity Read ↗

Ovarian hyperstimulation syndromeSemantic proximity Read ↗

Empty follicle syndrome after GnRHa triggering versus hCG triggering in COSSemantic proximity Read ↗

An extremely patient-friendly and efficient stimulation protocol for assisted reproductive technology in normal and high respondersSemantic proximity Read ↗

Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization cycles: a randomized, double-blind, placebo-controlled trialSemantic proximity Read ↗

The administration of glucocorticoids for the prevention of ovarian hyperstimulation syndrome in in vitro fertilization: a prospective randomized studySemantic proximity Read ↗

The optimal length of ‘coasting protocol’ in women at risk of ovarian hyperstimulation syndrome undergoingin vitrofertilizationSemantic proximity Read ↗

The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian responseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.